Literature DB >> 21576965

Restless legs syndrome in multiple sclerosis.

Gülay Aydar1, Semiha Kurt, Hatice Karaer Unaldi, Unal Erkorkmaz.   

Abstract

AIMS: Multiple sclerosis (MS) is a demyelinating neurodegenerative inflammatory autoimmune disease. Restless legs syndrome (RLS) is characterized as a strong urge to move the legs to stop abnormal sensations there. In this study, we aimed to investigate whether or not the increased RLS frequency seen in MS could be associated with depression and fatigue.
METHODS: The study involved 98 patients with definite MS and 129 healthy volunteers. The Beck Depression Inventory and Fatigue Severity Scale were used to assess all participants. The patients and the healthy volunteers were examined for RLS according to the criteria of the International Restless Legs Syndrome Study Group.
RESULTS: When the factors related to RLS in MS were evaluated, there were significant relationships found among age, type of MS, pyramidal symptoms, intestinal and bladder symptoms, number of lesions in MR, depression, and fatigue. Risk factors for RLS were also seen more frequently in the MS group than in the healthy volunteers.
CONCLUSION: RLS was seen 2.55 times more frequently in patients with MS than in the control group. This was due to the existence of numerous factors rather than a single factor - including depression and fatigue.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21576965     DOI: 10.1159/000327315

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  13 in total

1.  Restless leg syndrome in different types of demyelinating neuropathies: a single-center pilot study.

Authors:  Marco Luigetti; Alessandra Del Grande; Elisa Testani; Giulia Bisogni; Anna Losurdo; Nadia Mariagrazia Giannantoni; Salvatore Mazza; Mario Sabatelli; Giacomo Della Marca
Journal:  J Clin Sleep Med       Date:  2013-09-15       Impact factor: 4.062

2.  [Frequent neurological diseases associated with the restless legs syndrome].

Authors:  M Bartl; J Winkelmann; B Högl; W Paulus; C Trenkwalder
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

3.  Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.

Authors:  Y Li; K L Munger; S Batool-Anwar; K De Vito; A Ascherio; X Gao
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

4.  Restless leg syndrome and multiple sclerosis: a case-control study in China.

Authors:  Gangqiong Liu; Xiao Feng; Chao Lan; Ziqiang Zhu; Shengli Ma; Yu Guo; Rui Xue
Journal:  Sleep Breath       Date:  2015-05-24       Impact factor: 2.816

Review 5.  The Comorbidity of Migraine and Restless Legs Syndrome.

Authors:  Semiha Kurt
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-27       Impact factor: 5.081

6.  Restless legs syndrome in Iranian patients with multiple sclerosis.

Authors:  Shahnaz Miri; Mohammad Rohani; Mohammad Ali Sahraian; Babak Zamani; Gholam Ali Shahidi; Amin Sabet; Maziar Moradi-Lakeh; Mohammad Bodaghabadi
Journal:  Neurol Sci       Date:  2012-09-09       Impact factor: 3.307

7.  Impact, Frequency, and Severity of Restless Legs Syndrome in Patients with Multiple Sclerosis in Argentina.

Authors:  Edgar Carnero Contentti; Pablo A López; Debora Nadur; María Eugenia Balbuena; Ana Mariel Finkelstein; Verónica Tkachuk
Journal:  Int J MS Care       Date:  2019 Jul-Aug

8.  Restless Legs Syndrome in Patients with Behçet's Disease and Multiple Sclerosis: Prevalence, Associated Conditions and Clinical Features.

Authors:  Ayşenur Önalan; Zeliha Matur; Münevver Pehlıvan; Gülşen Akman
Journal:  Noro Psikiyatr Ars       Date:  2018-07-09       Impact factor: 1.339

9.  Restless Legs Syndrome in Multiple Sclerosis.

Authors:  Taşkın Güneş; Ufuk Emre; Yüksel Erdal; Osman Özgür Yalin
Journal:  Noro Psikiyatr Ars       Date:  2019-08-16       Impact factor: 1.339

10.  Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.

Authors:  Vahid Shaygannejad; Parisa Emami Ardestani; Majid Ghasemi; Rokhsareh Meamar
Journal:  Int J Prev Med       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.